CBS and chronic myelogenous leukemia, BCR-ABL1 positive: It has been revealed that inhibition of CBS by AOAA decreases the endogenous H2S levels, promotes mitochondria-mediated apoptosis, and inhibits the transcriptional activity of nuclear factor-kappa B in chronic myeloid leukemia-derived K562 cells [44].